Obitsu Yukio, Koizumi Nobusato, Iida Yasunori, Satou Kazuhiro, Watanabe Yoshiko, Takae Hisahito, Saiki Naozumi, Kawaguchi Satoshi, Shigematsu Hiroshi
Department of Vascular Surgery, Tokyo Medical University, Tokyo, Japan.
Ann Vasc Dis. 2008;1(1):40-4. doi: 10.3400/avd.AVDoa07001. Epub 2008 Feb 15.
We evaluated the operative results of our treatment for multiple aortic aneurysms by means of a hybrid procedure consisting of a combination of conventional surgical maneuvers and simultaneous or sequential endovascular aortic repair (EVAR).
From August 1998 to April 2007, a total of 15 patients, 11 men and 4 women, ranging in age from 62 to 78 years, were treated with hybrid procedures for multiple aortic aneurysms. The pathology of these patients were, atherosclerotic aneurysm in 12 patients, atherosclerotic aneurysm associated with chronic dissection in 2 and type III chronic dissection in 1 patient. The distribution of aneurysmal locations were as follows: 5 patients had aneurysms at the arch and descending aorta, 1 had at the arch and thoracoabdominal aorta, 6 at the descending and abdominal aorta. Two patients with chronic dissection had simultaneous abdominal aortic aneurysms. In all except 1 of the 7 patients who had abdominal aortic aneurysm, we performed abdominal aneurysmectomy and EVAR simultaneously. In 7 patients, EVAR was performed sequentially after graft replacement surgery. In 2 patients, EVAR was the initial procedure followed by conventional surgery. The mean interval between first and second stage procedures was approximately 4 months.
One patients died of methicillin resistant Staphylococcus aureus pneumonia 3 months after the simultaneous procedure, all others were discharged and survive. In particular, no major EVAR linked complication was observed in the follow-up period (range 3 to 91 months, mean 46 months).
The hybrid procedure for the treatment of multiple aortic aneurysmal disease is less invasive compared to conventional staged surgery and the outcome in terms of mortality and morbidity in hospital as well as long-term follow-up are satisfactory.
我们通过一种混合手术来评估我们对多发性主动脉瘤的治疗效果,该混合手术包括传统外科手术操作与同期或分期血管腔内主动脉修复术(EVAR)相结合。
1998年8月至2007年4月,共有15例患者接受了多发性主动脉瘤的混合手术治疗,其中男性11例,女性4例,年龄在62岁至78岁之间。这些患者的病理情况如下:12例为动脉粥样硬化性动脉瘤,2例为动脉粥样硬化性动脉瘤合并慢性夹层分离,1例为III型慢性夹层分离。动脉瘤的位置分布如下:5例患者的动脉瘤位于主动脉弓和降主动脉,1例位于主动脉弓和胸腹主动脉,6例位于降主动脉和腹主动脉。2例慢性夹层分离患者同时患有腹主动脉瘤。在7例患有腹主动脉瘤的患者中,除1例之外,其余患者均同时进行了腹主动脉瘤切除术和EVAR。7例患者在人工血管置换术后分期进行了EVAR。2例患者首先进行了EVAR,随后进行了传统手术。第一阶段和第二阶段手术之间的平均间隔时间约为4个月。
1例患者在同期手术后3个月死于耐甲氧西林金黄色葡萄球菌肺炎,其他患者均已出院并存活。特别是,在随访期间(范围为3至91个月,平均46个月)未观察到与EVAR相关的重大并发症。
与传统分期手术相比,用于治疗多发性主动脉瘤疾病的混合手术侵入性较小,在住院死亡率和发病率以及长期随访方面的结果均令人满意。